Back to ALLO
CITADEL ADVISORS LLC ALLO Position History
Allogene Therapeutics, Inc. • Healthcare
Quarters held
12
Latest value
$133K
Q2 2026
Peak value
$19.7M
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $14.1M |
| Q1 2026 | $150K |
| Q1 2026 | $2.4M |
| Q1 2026 | $78K |
| Q2 2026 | $19.7M |
| Q2 2026 | $149K |
| Q2 2026 | $1.3M |
| Q2 2026 | $133K |
| Q2 2026 | $19.7M |
| Q2 2026 | $149K |
| Q2 2026 | $1.3M |
| Q2 2026 | $133K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $133K | 63.8K | — | — |
| Q2 2026 | $1.3M | 627.7K | — | — |
| Q2 2026 | $149K | 71.8K | — | — |
| Q2 2026 | $19.7M | 9.46M | — | — |
| Q2 2026 | $133K | 63.8K | — | — |
| Q2 2026 | $1.3M | 627.7K | — | — |
| Q2 2026 | $149K | 71.8K | — | — |
| Q2 2026 | $19.7M | 9.46M | — | — |
| Q1 2026 | $78K | 32.0K | — | — |
| Q1 2026 | $2.4M | 998.4K | — | — |
| Q1 2026 | $150K | 61.5K | — | — |
| Q1 2026 | $14.1M | 5.80M | — | — |